Related references
Note: Only part of the references are listed.Prognostic implications of chronic kidney disease and anemia after percutaneous coronary intervention in acute myocardial infarction patients
Yuya Matsue et al.
HEART AND VESSELS (2013)
Acidic urine is associated with poor prognosis in patients with chronic heart failure
Yoichiro Otaki et al.
HEART AND VESSELS (2013)
Effect of lipo-prostaglandin E1 on cystatin C, β2-microglobulin, and estimated glomerular filtration rate in patients with decompensated heart failure and renal dysfunction: a single-center, nonrandomized controlled study
Zhi-Qiang Hou et al.
HEART AND VESSELS (2013)
Association between deteriorated renal function and long-term clinical outcomes after percutaneous coronary intervention
Manabu Ogita et al.
HEART AND VESSELS (2012)
Impact of chronic kidney disease on the severity of initially diagnosed coronary artery disease and the patient prognosis in the Japanese population
Hidenori Yagi et al.
HEART AND VESSELS (2011)
Long-term impact of mild chronic kidney disease in patients with acute coronary syndrome undergoing percutaneous coronary interventions
Tomotaka Dohi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
Kunihiro Matsushita et al.
LANCET (2010)
Effects of fenofibrate on lipid profiles, cholesterol ester transfer activity, and in-stent intimal hyperplasia in patients after elective coronary stenting
Tetsuro Miyazaki et al.
LIPIDS IN HEALTH AND DISEASE (2010)
Cystatin C in Acute Heart Failure Without Advanced Renal Impairment
Hiroyuki Naruse et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Prevalence of chronic kidney disease in the Japanese general population
Enyu Imai et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2009)
Cystatin C for Enhancement of Risk Stratification in Non-ST Elevation Acute Coronary Syndrome Patients with an Increased Troponin T
Fons Windhausen et al.
CLINICAL CHEMISTRY (2009)
Impact of Kidney Disease and Blood Pressure on the Development of Cardiovascular Disease An Overview From the Japan Arteriosclerosis Longitudinal Study
Toshiharu Ninomiya et al.
CIRCULATION (2008)
Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP
Johan Lassus et al.
EUROPEAN HEART JOURNAL (2007)
Cystatin C as a risk factor for outcomes in chronic kidney disease
Vandana Menon et al.
ANNALS OF INTERNAL MEDICINE (2007)
Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction - The Cardiovascular Health Study
Mathew S. Maurer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease - Data from the Heart and Soul Study
Joachim H. Ix et al.
CIRCULATION (2007)
GFR estimation using cystatin C is not independent of body composition
Jamie Macdonald et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Disruption of the Cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation
E Lutgens et al.
CIRCULATION (2006)
Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice
E Bengtsson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Cystatin C and the risk of death and cardiovascular events among elderly persons
MG Shlipak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Cystatin C concentration as a risk factor for heart failure in older adults
MJ Sarnak et al.
ANNALS OF INTERNAL MEDICINE (2005)
Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: More than simply a marker of glomerular filtration rate
W Koenig et al.
CLINICAL CHEMISTRY (2005)
Cystatin-C and mortality in elderly persons with heart failure
MG Shlipak et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement
EL Knight et al.
KIDNEY INTERNATIONAL (2004)
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction
NS Anavekar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Cysteine protease cathepsin F is expressed in human atherosclerotic lesions, is secreted by cultured macrophages, and modifies low density lipoprotein particles in vitro
K Öörni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Lysosomal cysteine proteases in atherosclerosis
JA Liu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Cystatin C - A novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome
T Jernberg et al.
CIRCULATION (2004)
Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency
CY Hsu et al.
KIDNEY INTERNATIONAL (2002)
Share Paper
